F

FATE

Fate Therapeutics Inc

2.45

Jul 31 • 3:59 PM ET -0.06 (-2.39%)

2.42

Aftermarket • 7:39 PM ET -0.03 (-1.09%)

Healthcare Biotechnology USA Micro NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: VTI VXF SCHA IWC VHT PRFZ BUSM SCHB AVSC DFMC

Scroll to Statements

Index	-
Market Cap	285.57M
Enterprise Value	187.53M
Income	-129.91M
Sales	6.32M
Book/sh	1.55
Cash/sh	1.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	45.19
P/B	1.59
P/C	1.63
P/FCF	-
EV/EBITDA	-
EV/Sales	29.67
Quick Ratio	5.85
Current Ratio	5.85
Debt/Eq	0.43
LT Debt/Eq	0.40
Option/Short	Yes / Yes

EPS (ttm)	-1.09
EPS next Y	-1.03
EPS next Q	-0.27
EPS this Y	5.93%
EPS next Y	4.70%
EPS next 5Y	2.41%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	26.97%
Sales Y/Y TTM	-52.64%
EPS Q/Q	18.19%
Sales Q/Q	-20.26%
Earnings	May 13 BMO
EPS/Sales Surpr.	7.14% -12.93%

Insider Own	5.16%
Insider Trans	-0.90%
Inst Own	60.73%
Inst Trans	3.52%
ROA	-38.01%
ROE	-55.50%
ROIC	-51.60%
Gross Margin	-97.69%
Oper. Margin	-2207.47%
Profit Margin	-2056.79%
SMA20	-10.69%
SMA50	0.55%
SMA200	56.04%
Trades

Shs Outstand	116.27M
Shs Float	110.55M
Short Float	6.62%
Short Ratio	1.75
Short Interest	7.32M
52W High	3.23 -24.15%
52W Low	0.91 169.23%
Volatility	7.23% 8.17%
ATR (14)	0.22
RSI (14)	46.17
Beta	2.53
Rel Volume	0.35
Avg Volume	4.17M
Volume	1,459,168

Perf Week	1.66%
Perf Month	-18.87%
Perf Quarter	96.00%
Perf Half Y	105.88%
Perf YTD	149.34%
Perf Year	122.73%
Perf 3Y	-40.68%
Perf 5Y	-97.04%
Perf 10Y	18.36%
Recom	2.00
Target Price	5.41
Prev Close	2.51
Price	2.45
Change	-2.39%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)